SAN FRANCISCO--(BUSINESS WIRE)--ixlayer, the leading platform for health testing, today announced the continued expansion of its collaborations with biopharma innovators. Adding to a growing list of relationships in the biopharma space, ixlayer supports advances in digital therapeutics and decentralized clinical trials (DCTs), with remote diagnostic testing capabilities that enable patient support and clinical research technologies to realize the full potential of their impact on patient care.
BrightInsight is a California-based IoT platform that provides patient engagement analytics and dashboard solutions for biopharma and healthcare sectors in the USA and Europe.